Merit Medical Systems (Nasdaq:MMSI) announced today that it received FDA premarket approval for its Wrapsody cell-impermeable endoprosthesis. With approval, the company can begin commercializing the device in the U.S. in 2025. South Jordan, Utah–based Merit Medical designed Wrapsody to extend long-term vessel patency in dialysis patients. It … [Read more...] about FDA approves Merit Medical’s cell-impermeable endoprosthesis
Merit Medical
Merit Medical completes acquisition of Cook Medical’s lead management portfolio
Merit Medical Systems (Nasdaq:MMSI) announced today that it completed its acquisition of Cook Medical’s lead management portfolio. South Jordan, Utah-based Merit announced its agreement to buy the portfolio for $210 million in September. Merit funded the acquisition through a combination of cash on hand and borrowings under a long-term credit … [Read more...] about Merit Medical completes acquisition of Cook Medical’s lead management portfolio
Merit Medical to buy Cook Medical’s lead management portfolio
Merit Medical Systems (Nasdaq:MMSI) announced today that it agreed to acquire Cook Medical's lead management portfolio for $210 million. Cook Medical's lead management business provides medical devices and accessories used in lead management procedures. These procedures occur in patients who need a pacemaker or an implantable … [Read more...] about Merit Medical to buy Cook Medical’s lead management portfolio
Merit Medical launches expanded Maestro microcatheter line
Merit Medical Systems this week announced the launch of its expanded Maestro microcatheter product line. The Maestro product line features embolotherapy devices, which include Embosphere Microspheres. The new 165 cm Maestro length will be available in 2.1F, 2.4F, 2.8F and 2.9F catheter diameters to support a broad range of embolization … [Read more...] about Merit Medical launches expanded Maestro microcatheter line
Merit Medical spends $132.5M on acquisitions to expand its offerings
AngioDynamics (Nasdaq:ANGO) announced that it completed the sale of its dialysis product portfolio to Merit Medical Systems. It was part of a series of product acquisitions worth $132.5 million that Merit (Nasdaq: MMSI) has announced. Latham, New York-based AngioDynamics sold its dialysis portfolio and the BioSentry product for $100 million … [Read more...] about Merit Medical spends $132.5M on acquisitions to expand its offerings
Merit Medical launches new Prelude Roadster guide sheath
Merit Medical Systems (Nasdaq:MMSI) announced today that it commercially released its Prelude Roadster guide sheath. South Jordan, Utah-based Merit designed its Prelude Roadster for deliverability, visibility, and resilience in tortuous peripheral vasculature anatomies. It helps to deliver devices used to diagnose and treat patients with … [Read more...] about Merit Medical launches new Prelude Roadster guide sheath
Freudenberg Medical acquires Merit Medical’s hypotubing business
Freudenberg Medical today said it has acquired Merit Medical's hypotube manufacturing business for an undisclosed amount. The acquisition will be absorbed by Freudenberg Medical's Cambus Medical in Galway, Ireland. Cambus Medical is a hypotube manufacturer for the minimally invasive industry. It develops and manufactures hypotubes, specialty … [Read more...] about Freudenberg Medical acquires Merit Medical’s hypotubing business